Published in J Med Chem on June 11, 2014
The future for early-stage tuberculosis drug discovery. Future Microbiol (2015) 0.84
The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis. Antimicrob Agents Chemother (2015) 0.79
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis. Sci Rep (2016) 0.75
Characterization of DprE1-mediated benzothiazinone resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2016) 0.75
Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds. Pharmaceuticals (Basel) (2017) 0.75
Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med (2005) 6.10
Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science (2003) 5.50
M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) (2004) 4.38
Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis. Antimicrob Agents Chemother (2003) 3.76
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science (2009) 3.39
Dynamic persistence of antibiotic-stressed mycobacteria. Science (2013) 3.34
Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc Natl Acad Sci U S A (2003) 3.14
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathog (2009) 2.76
Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect Immun (2005) 2.74
Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol (2007) 2.70
Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Microbiol (2006) 2.39
Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon. J Bacteriol (2006) 2.33
Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol (2004) 2.26
A novel mammalian flavin-dependent histone demethylase. J Biol Chem (2009) 2.25
Carbon metabolism of intracellular bacteria. Cell Microbiol (2006) 2.17
Human histone demethylase LSD1 reads the histone code. J Biol Chem (2005) 2.14
Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. Antimicrob Agents Chemother (2006) 2.14
Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat Immunol (2003) 2.03
Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev (2006) 2.02
Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis. Antimicrob Agents Chemother (2004) 1.99
New tuberculosis drugs on the horizon. Curr Opin Microbiol (2011) 1.94
Structural basis of LSD1-CoREST selectivity in histone H3 recognition. J Biol Chem (2007) 1.92
Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett (2005) 1.82
Functional characterization of a vitamin B12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids. J Bacteriol (2008) 1.82
Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol (2012) 1.79
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis. Sci Transl Med (2012) 1.78
A problem of persistence: still more questions than answers? Nat Rev Microbiol (2013) 1.68
Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci U S A (2005) 1.65
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2004) 1.64
Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol Microbiol (2003) 1.62
Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis. Mol Microbiol (2006) 1.61
The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Mol Med (2002) 1.58
Optimization of halopemide for phospholipase D2 inhibition. Bioorg Med Chem Lett (2007) 1.58
LSD1: oxidative chemistry for multifaceted functions in chromatin regulation. Trends Biochem Sci (2008) 1.54
A highly specific mechanism of histone H3-K4 recognition by histone demethylase LSD1. J Biol Chem (2006) 1.53
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrob Agents Chemother (2011) 1.51
Role of the methylcitrate cycle in propionate metabolism and detoxification in Mycobacterium smegmatis. Microbiology (2007) 1.50
Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother (2010) 1.43
Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. Vaccine (2009) 1.38
Towards a new tuberculosis drug: pyridomycin - nature's isoniazid. EMBO Mol Med (2012) 1.36
DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters. J Bacteriol (2002) 1.35
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia. J Biol Chem (2002) 1.34
Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs. Infect Immun (2004) 1.34
Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1. J Am Chem Soc (2011) 1.33
Mycobacterium tuberculosis FurA autoregulates its own expression. J Bacteriol (2003) 1.32
ThermoFAD, a Thermofluor-adapted flavin ad hoc detection system for protein folding and ligand binding. FEBS J (2009) 1.32
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis. Antimicrob Agents Chemother (2012) 1.31
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol (2009) 1.30
Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates. Antimicrob Agents Chemother (2012) 1.29
Mycobacterium tuberculosis: drug resistance and future perspectives. Future Microbiol (2009) 1.29
Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. J Antimicrob Chemother (2008) 1.28
Towards a new combination therapy for tuberculosis with next generation benzothiazinones. EMBO Mol Med (2014) 1.27
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol (2006) 1.26
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system. Tuberculosis (Edinb) (2008) 1.24
Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch Biochem Biophys (2007) 1.23
Ribonucleotide reduction in Mycobacterium tuberculosis: function and expression of genes encoding class Ib and class II ribonucleotide reductases. Infect Immun (2003) 1.23
mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob Agents Chemother (2005) 1.23
Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms. Antimicrob Agents Chemother (2011) 1.22
Alternative splicing of the histone demethylase LSD1/KDM1 contributes to the modulation of neurite morphogenesis in the mammalian nervous system. J Neurosci (2010) 1.22
Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria. Nat Commun (2013) 1.21
Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis. J Med Chem (2008) 1.21
Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. Biochemistry (2009) 1.21
Functional role of the "aromatic cage" in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins. Biochemistry (2006) 1.21
Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. Blood (2009) 1.19
The Mycobacterium tuberculosis Rv2358-furB operon is induced by zinc. Res Microbiol (2004) 1.19
Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors. J Biol Chem (2005) 1.18
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS One (2011) 1.14
Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice. Proc Natl Acad Sci U S A (2010) 1.13
Development of a repressible mycobacterial promoter system based on two transcriptional repressors. Nucleic Acids Res (2010) 1.13
Explicit ion, implicit water solvation for molecular dynamics of nucleic acids and highly charged molecules. J Comput Chem (2008) 1.13
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance. Mol Microbiol (2010) 1.12
A priori theoretical prediction of selectivity in asymmetric catalysis: design of chiral catalysts by using quantum molecular interaction fields. Angew Chem Int Ed Engl (2006) 1.11
In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother (2013) 1.10
Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS One (2008) 1.09
Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV). Proc Natl Acad Sci U S A (2011) 1.08
Molecular mimicry and ligand recognition in binding and catalysis by the histone demethylase LSD1-CoREST complex. Structure (2011) 1.06